FAZQOVRI Trademark

Trademark Overview

On Monday, September 22, 2025, a trademark application was filed for FAZQOVRI with the United States Patent and Trademark Office. The USPTO has given the FAZQOVRI trademark a serial number of 99405340. The federal status of this trademark filing is PUBLICATION/ISSUE REVIEW COMPLETE as of Thursday, January 15, 2026. This trademark is owned by Pfizer Inc.. The FAZQOVRI trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of autoimmune, cardiovascular, endocrine, gastrointestinal, genetic, infectious, inflammatory, kidney, liver, menopausal, metabolic, musculoskeletal, neurodegenerative, neurological, neuromuscular, respiratory, and viral diseases and disorders; Pharmaceutical preparations for the treatment of blood disorders, bone growth disorders, hormonal disorders, skin disorders, arthritis, cancer, cachexia, hypertension, migraine, pain, stroke, obesity and diabetes; Pharmaceuticals, namely, anti-infectives; Medicated dermatological preparations and substances; Antifungal preparations; Smoking cessation preparations; Vaccines for human use
fazqovri

General Information

Serial Number99405340
Word MarkFAZQOVRI
Filing DateMonday, September 22, 2025
Status681 - PUBLICATION/ISSUE REVIEW COMPLETE
Status DateThursday, January 15, 2026
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements

Goods and ServicesPharmaceutical preparations for the treatment of autoimmune, cardiovascular, endocrine, gastrointestinal, genetic, infectious, inflammatory, kidney, liver, menopausal, metabolic, musculoskeletal, neurodegenerative, neurological, neuromuscular, respiratory, and viral diseases and disorders; Pharmaceutical preparations for the treatment of blood disorders, bone growth disorders, hormonal disorders, skin disorders, arthritis, cancer, cachexia, hypertension, migraine, pain, stroke, obesity and diabetes; Pharmaceuticals, namely, anti-infectives; Medicated dermatological preparations and substances; Antifungal preparations; Smoking cessation preparations; Vaccines for human use

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, September 22, 2025
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NamePfizer Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressNew York, NY 10001-2192

Trademark Events

Event DateEvent Description
Monday, September 22, 2025NEW APPLICATION ENTERED
Monday, September 22, 2025NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, September 22, 2025APPLICATION FILING RECEIPT MAILED
Monday, January 12, 2026ASSIGNED TO EXAMINER
Monday, January 12, 2026APPROVED FOR PUB - PRINCIPAL REGISTER

Related Keywords

fazqovri disorders preparations pharmaceutical treatment stroke pain obesity diabetes migraine cachexia